# A Trial to Examine if Repinatrabit is Processed Differently in Adults With Reduced Liver or Kidney Function Compared to Adults With Normal Liver and Kidney Function

> **NCT07713758** · PHASE1 · RECRUITING · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 32 (estimated)

## Conditions studied

- Phenylketonuria

## Interventions

- **DRUG:** Repinatrabit

## Key facts

- **NCT ID:** NCT07713758
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-17
- **Primary completion:** 2027-02-09
- **Final completion:** 2027-02-15
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07713758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07713758, "A Trial to Examine if Repinatrabit is Processed Differently in Adults With Reduced Liver or Kidney Function Compared to Adults With Normal Liver and Kidney Function". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07713758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*